Bharat Biotech and Serum Institute of India have approached Drugs Controller General of India requesting a change in factsheets on their vaccines that rule them out for those on blood thinners.
India’s vaccination strategy is smartly-designed and will strengthen healthcare workers to handle a second wave, says Dr V. Ravi, former basic sciences dean at NIMHANS.
Covaxin is contraindicated for people who use blood thinners, while Covishield asks recipients to inform physician. But doctors say there’s no rationale.
A preprint of the results were released last month, which revealed that all three vaccine formulations in the trial resulted in 'robust immune responses'.
Several institutes and experts advocate see this as an efficacy trial that could help boost confidence in vaccines, especially Bharat Biotech’s Covaxin that is in phase-3 trials.
Punjab, Uttarakhand & Assam plan to publish ads in newspapers, while Delhi is holding awareness sessions & interpersonal discussions to remove doubts over Covid vaccines.
While the commission didn’t mention provisions under which IndiGo's market domination would be examined, Competition Act 2002 prohibits abuse of dominant position by any enterprise.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
I received the AZ vaccine, I am on clopidogrel. There was no side effects except pain at the injection point.